Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3721 AL 3735

Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis

Chuang CL, Demontis F.

Ageing Res Rev. 2021 Aug;69:101358. doi: 10.1016/j.arr.2021.101358. Epub 2021 May 9.

Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy

Garcia Ruiz PJ.

Mov Disord Clin Pract. 2021 Mar 9;8(4):521-524. doi: 10.1002/mdc3.13180. eCollection 2021 May.

Role of ARK5 in cancer and other diseases (Review)

Mo G, Zhang B, Jiang Q.

Exp Ther Med. 2021 Jul;22(1):697. doi: 10.3892/etm.2021.10129. Epub 2021 May 2.

Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies

Domin H.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110349. doi: 10.1016/j.pnpbp.2021.110349. Epub 2021 May 13.

Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease

Zhang X, Alshakhshir N, Zhao L.

Front Neurosci. 2021 Apr 28;15:662242. doi: 10.3389/fnins.2021.662242. eCollection 2021.

The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

Martinez NW, Gómez FE, Matus S.

Front Aging Neurosci. 2021 Apr 28;13:638208. doi: 10.3389/fnagi.2021.638208. eCollection 2021.

Taming the Huntington's Disease Proteome: What Have We Learned?

Seeley C, Kegel-Gleason KB.

J Huntingtons Dis. 2021;10(2):239-257. doi: 10.3233/JHD-200465.

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Xu C, Wang YN, Wu H.

J Med Chem. 2021 May 27;64(10):6549-6565. doi: 10.1021/acs.jmedchem.1c00325. Epub 2021 May 17.

[Neurological Manifestations in Antiphospholipid Syndrome]

Abe N, Atsumi T.

Brain Nerve. 2021 May;73(5):526-536. doi: 10.11477/mf.1416201795.

Bilateral chorea following severe traumatic brain injury treated with risperidone

Krasna D, Montgomery E, Koffer J, Segal M.

BMJ Case Rep. 2021 May 19;14(5):e241929. doi: 10.1136/bcr-2021-241929.

Bioinformatic analysis of the human brain extracellular matrix proteome in neurodegenerative disorders

Freitas A, Aroso M, Rocha S, Ferreira R, Vitorino R, Gomez-Lazaro M.

Eur J Neurosci. 2021 Jun;53(12):4016-4033. doi: 10.1111/ejn.15316. Epub 2021 Jun 16.

Movement Disorders in Children

Jain R, Pandey S, Raghav S.

Indian Pediatr. 2021 Sep 15;58(9):861-870. Epub 2021 May 20.

Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders

Paul R, Nath J, Paul S, Mazumder MK, Phukan BC, Roy R, Bhattacharya P, Borah A.

Neurochem Int. 2021 Sep;148:105068. doi: 10.1016/j.neuint.2021.105068. Epub 2021 May 20.

Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases

Do HA, Baek KH.

Ageing Res Rev. 2021 Aug;69:101367. doi: 10.1016/j.arr.2021.101367. Epub 2021 May 21.

Requirements for a Robust Animal Model to Investigate the Disease Mechanism of Autoimmune Complications Associated With ARF/RHD

Rafeek RAM, Sikder S, Hamlin AS, Andronicos NM, McMillan DJ, Sriprakash KS, Ketheesan N.

Front Cardiovasc Med. 2021 May 5;8:675339. doi: 10.3389/fcvm.2021.675339. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias